COMPOUND PROFILE / PEPTIDES & ANALOGUES
SHLP2.
Research draftSHLP2 is a small Humanin-like mitochondrial-derived peptide.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
SHLP2 is a small Humanin-like mitochondrial-derived peptide.
Mechanism
Experimental studies examine stress responses, inflammatory signalling and cellular metabolism.
Human research
Human biomarker research does not establish therapeutic benefit from administration.
Preclinical & other research
Mouse asthma and lung-cell experiments reported inflammatory and injury-response effects.
Safety & unknowns
Therapeutic exposure and long-term human safety are not established.
Regulatory status
Preclinical research candidate, not an established immune or longevity therapy.
Reported use & evidence
The supplied SHLP2 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.